Abiopharma

Clinical trial NCT05993234: status: RECRUITING → ACTIVE_NOT_RECRUITING.

Clinical trial NCT04151667 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-07 → 2026-03-16

New Form 424B2 - TORONTO DOMINION BANK <b>Filed:</b> 2026-08-20 <b>AccNo:</b> 0001140361-26-033829 <b>Size:</b> 415 KB

Clinical trial NCT07504601: start date: 2026-08-24 → 2026-08-25.

Clinical trial NCT05335928 updates: 1. completion date: 2027-04-20 → 2029-10-09 2. primary completion date: 2026-11-20 → 2029-04-09

Clinical trial NCT07549490: start date: 2026-08-24 → 2026-08-25.

Clinical trial NCT05614739: enrollment: 535 → 677 participants.

Clinical trial NCT07021989 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-10-01 → 2026-08-18

Clinical trial NCT07494045 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-01 → 2026-08-05

Wix.com Ltd. (WIX) Investors: September 22, 2026 Lead Plaintiff Deadline in Class Action Lawsuit

Whirlpool Corporation Recognized by Seramount for Workplace Inclusion and Talent Leadership

PROCEPT BioRobotics Corporation (PRCT) Investors: September 22, 2026 Lead Plaintiff Deadline in Class Action Lawsuit

Cogent Communications Holdings (CCOI) Investors: September 21, 2026 Lead Plaintiff Deadline in Class Action Lawsuit

Cosmos Health Enters Saudi Arabia Through Exclusive Distribution Agreement With Innova Healthcare; Secures Initial Purchase Order of 126,000 Sky Premium Life Units, With More Than 5 Million Units Expected Over Initial 5-Year Term

Polyrizon Completes Clinical Site Network for NASARIX™ Study and Advances Toward Patient Enrollment